Tc99mDTPAStabilityAndTranschelationChecker

Utility description: Tc-99m DTPA Stability And Transchelation Checker

Tc-99m DTPA Stability And Transchelation Checker — Technetium-99m DTPA for dynamic scintigraphy

ℹ️  Utility checks critical parameters of Tc-99m DTPA:
    • Radiochemical purity (≥95%)
    • Free pertechnetate (≤5%)
    • Reduced/hydrolyzed technetium (≤5%)
    • Transchelation (≤5%) — CRITICAL!
    • Aluminum oxide (<5 ppm)
    • pH (4.0-8.0)
    • Endotoxins (<175 EU/mL)
    • Sterility, heavy metals, stability time (≤6 hours)

⚠️  CRITICAL: Transchelation >5% → accumulation in liver and spleen!
    Low RCP <95% → kidney and brain imaging artifacts!
    Stability time exceedance >6h → complex degradation and reduced clearance!

Usage:
  Tc99mDTPAStabilityAndTranschelationChecker.exe                            → demo mode (console output)
  Tc99mDTPAStabilityAndTranschelationChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,RadiochemicalPurityPercent,FreePertechnetatePercent,ReducedHydrolyzedTechnetiumPercent,TranschelationPercent,AluminumOxidePPM,pH,EndotoxinsEU_per_mL,SterilityTest,HeavyMetalsPPM,HoursSincePreparation,ActivityMBq

Example (sterility: 0=sterile, 1=contaminated):
  TC99M-DTPA-2026-001,96.5,1.8,1.7,2.0,3.0,6.5,45.0,0,4.0,3.0,800.0

— WHY IS THIS NEEDED?
Technetium-99m DTPA (diethylenetriaminepentaacetic acid) — widely used radiopharmaceutical:
• 6.02-hour half-life — optimal for diagnostics
• 140 keV gamma radiation — ideal for gamma cameras
• Rapid renal clearance (glomerular filtration) — gold standard for GFR assessment
• Also used for brain scintigraphy (blood-brain barrier disruption)
• Clinically proven efficacy in kidney function assessment, obstruction, reflux

⚠️  CRITICAL:
• Radiochemical purity ≥95% — ensures rapid excretion through kidneys without delay
• Free pertechnetate ≤5% — free Tc-99m accumulates in thyroid, stomach, salivary glands
• Reduced/hydrolyzed technetium ≤5% — colloidal technetium is taken up by liver and spleen
• Transchelation ≤5% — CRITICAL PARAMETER! Tc-99m can transfer to endogenous ligands (transferrin, albumin), leading to accumulation in liver, spleen, and bone marrow instead of rapid renal clearance
• Aluminum oxide <5 ppm — excess Al³⁺ disrupts complexation
• pH 4.0-8.0 — DTPA is more stable over a wide pH range compared to DMSA
• Endotoxins <175 EU/mL — critical for IV administration!
• Sterility — MANDATORY for all parenteral forms!
• Usage time ≤6 hours — although DTPA is more stable than DMSA, prolonged storage increases transchelation risk

Key features:
• Radiochemical purity check (main quality parameter)
• Control of two main impurities: free pertechnetate and reduced technetium
• Transchelation monitoring — unique parameter for DTPA, distinguishing it from other complexes
• Aluminum oxide monitoring as critical labeling quality factor
• pH control for complex stability assurance
• Time since preparation and minimum activity check
• Comprehensive microbiological safety assessment

Critical parameters:
• Radiochemical purity: ≥95.0%
• Free pertechnetate: ≤5.0%
• Reduced/hydrolyzed technetium: ≤5.0%
• Transchelation: ≤5.0% (CRITICAL!)
• Aluminum oxide: <5.0 ppm
• pH: 4.0–8.0
• Endotoxins: <175 EU/mL
• Sterility: no microbial growth
• Heavy metals: ≤10 ppm
• Stability time: ≤6 hours
• Minimum activity: ≥200 MBq

💡 Usage tips:
1. Radiochemical purity controlled by TLC or HPLC with radio-detector
2. Transchelation determined by incubating the preparation with blood plasma in vitro and analyzing activity distribution
3. Free pertechnetate determined on silica gel strips (mobile phase: acetone)
4. Colloidal technetium determined on paper (mobile phase: saline)
5. Aluminum controlled by colorimetric method or ICP-MS
6. All measurements should be performed within 6 hours after synthesis
7. If transchelation >5% — batch rejected (critical parameter for clinical use)!

⚠️ Note: Tc-99m DTPA is one of the most important diagnostic radiopharmaceuticals for nephrology and neurology. Transchelation is a unique problem for DTPA, as the complex is less stable than, for example, Tc-99m MAG3. High transchelation leads to false results: instead of rapid renal clearance, accumulation in liver and spleen is observed, mimicking pathology. Control of this parameter is MANDATORY before clinical use.